The first in-human trial of a CRISPR Cas system delivered by adeno-associated virus 9 gene therapy to treat HIV was able to target only the intended DNA and cleared the blood within 6 months.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback